Anzeige
Mehr »
Login
Freitag, 03.05.2024 Börsentäglich über 12.000 News von 685 internationalen Medien
Schnelle Produktionsaufnahme: Multi-Tenbagger-Potenzial direkt in Spanien?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
37 Leser
Artikel bewerten:
(0)

Research and Markets - Global Women's Health Market to Grow 3.84% - Key Vendors are Allergan, Merck & Pfizer

DUBLIN, April 26, 2016 /PRNewswire/ --

Research and Markets has announced the addition of the "Global Women's Health Market 2016-2020" report to their offering.

The global women's health market is set to grow at a CAGR of 3.84% during the period 2016-2020.

(Logo: http://photos.prnewswire.com/prnh/20160330/349511LOGO )

Women's health refers to the overall well-being experienced by women - this includes physical, mental, and social well-being. It deals with the diagnosis and treatment of various diseases and conditions that affect women such as HIV/AIDS, endometriosis, infertility, polycystic ovary syndrome, postmenopausal osteoporosis, and cancer (primarily ovarian and breast cancer).

The limited funding for public health clinics globally has led to a rise in common STIs such as chlamydia, syphilis, and gonorrhea. Such diseases should be treated urgently as they can cause pelvic inflammatory diseases, stillbirths, neonatal infections, and infertility. Various public health institutes highly recommend that women who are sexually active must undergo STI screening once a year. The increase in detections of STIs will positively affect this market.

According to the report, the rise in the number of older women worldwide has spurred the market, with companies investing in R&D to develop new women's health solutions to enhance their existing portfolio. Many of the diseases women are diagnosed with are associated with old age. This will fuel the growth of the women's health market over the forecast period.

Further, the report states that one of the major issues faced by women is the cost of treatment and the inaccessibility of therapies to treat diseases, especially in developing and under-developing countries.

Key vendors:

  • Allergan
  • Bayer HealthCare
  • Merck
  • Pfizer
  • Teva Pharmaceuticals

Key questions answered in this report:

  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

Key Topics Covered:

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Market research methodology

PART 04: Introduction

PART 05: Market landscape

PART 06: Market segmentation by application

PART 07: Geographical segmentation

PART 08: Market drivers

PART 09: Impact of drivers

PART 10: Market challenges

PART 11: Impact of drivers and challenges

PART 12: Market trends

PART 13: Vendor landscape

PART 14: Key vendor analysis

For more information visit http://www.researchandmarkets.com/research/xvtf26/global_womens


Media Contact:
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Lithium vs. Palladium - Zwei Rohstoff-Chancen traden
In diesem kostenfreien PDF-Report zeigt Experte Carsten Stork interessante Hintergründe zu den beiden Rohstoffen inkl. . Zudem gibt er Ihnen konkrete Produkte zum Nachhandeln an die Hand, inkl. WKNs.
Hier klicken
© 2016 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.